NewsRx

Search our medical news database

FDA Law Weekly

Susan Hasty, Publisher

Table of Contents . . . September 16th, 2004

Non-Subscriber - Summaries Only

Related Areas: Other Issues in FDA Law Weekly | Other Publications

Abbott Laboratories - FDA clears test that aids in heart attack detection

Advanced Bionics - HiResolution bionic ear system proven safe for MRI

Arthritis Drug - Merck defends arthritis drug's safety after critical FDA study

Aventis - FDA approves Taxotere for the treatment of women with early-stage breast cancer

Avian Influenza - World Health Organization says more funding needed to investigate bird flu

Best Practices, LLC - Research firm finds employee development and staffing tactics increase compliance

Best Practices, LLC - Study shows few pharmaceutical companies have moved to assure brand security

BioPort Corporation - IND accepted by FDA for anthrax immunity-stimulating molecule

Boston Scientific Corp. - FDA approves extension of expiration date for TAXUS Express2 stent system

Business Update - Specialty hospitals grow, but financial performance mixed

Cardiac Science, Inc. - FDA grants clearance to market Powerheart AED G3 PRO defibrillator

Chiron Corp. - Company produces further pandemic-like influenza vaccines for NIH studies

Columbia University - FDA updates its review of antidepressant drugs in children

Concentric Medical - FDA clears device for removing blood clots in stroke patients

Dalhousie University - West Nile virus screening of donated organs counterproductive

Agennix, Inc. - Anticancer activity of natural immunomodulatory protein reported

Amgen, Inc. - Acquisition of Tularik completed

Bariatric Surgery - Bariatric Surgery Centers of Excellence program launched in Pennsylvania, Ohio

Barrier Therapeutics, Inc. - Dermatology firm reports loss of $0.66 per share

Baxter Healthcare S.A. - Positive opinion issued from French authorities for reimbursement of Advate

Baylor College of Medicine - Therapeutic targeting of CD18 integrins to exclude homing holds promise

Bio-One Corporation - Nutritional supplements firm reports second quarter revenue of $10.9M

Biovail Corporation - Regulatory approval granted for Tiazac XC in Canada

Bolder BioTechnology, Inc. - Protein engineering pharma company gets NIH grant for MS drug

Brigham and Women's Hospital - PPAR-gamma protects against acute gastric mucosal lesions

CEA Saclay - Immunoprecipitation of prion protein mediated by antibodies

CardioSpecialists Group Ltd - Lipid-lowering agents reduce cardiovascular event risk

Carrington Laboratories, Inc. - Pharmaceutical firm reports $7.99 in revenues

ChemDiv, Inc. - Yale University, collaborator receive phase I NIH grant for MC2R discovery

Childhood Obesity - Group supports childhood obesity reduction legislation

Children's Hospital of Philadelphia - High-dose steroids do not always cause bone loss in children

Children's National Medical Center - Virus-mediated p14(ARF) expression prompts apoptosis in osteosarcoma cells

Chinese University of Hong Kong - Environment and diet may explain different rates of asthma

Chiral Quest, Inc. - Pharmaceutical company introduces new name, VioQuest Pharmaceuticals, Inc.

Chromos Molecular Systems, Inc. - Cell-therapy company updates Q2, reports $1.4 million net loss

Cincinnati Children's Hospital - Study identifies rapidly rising disorder

Clarigen Inc. - Extracorporeal device efficiently removes endotoxin from whole blood

Cleveland Clinic Foundation - Nitric oxide synthase-2 pathway signals are impaired in cystic fibrosis

Cleveland Clinic Foundation - WBC count predicts long-term mortality after percutaneous coronary intervention

Columbia University - Gene expression in biopsy specimens has prognostic value

Cornell University - Surface peptidase expressed during wound healing is a tumor suppressor

Coronado Industries, Inc. - Glaucoma-device maker updates European activities

Curtin University of Technology - Domestic solvents, cleaning products may increase childhood asthma risk

Cytogen Corporation - Study shows improved 3-year biochemical control of recurrent prostate cancer

DOR BioPharma, Inc. - Biopharmaceutical company announces Q2 net loss of $1,473,376, updates progress

Dana-Farber Cancer Institute - Monoclonal antibody conjugate has potent antimyeloma activity

Dr. Harisingh Gour University - Cholera toxin bile-salt-stabilized vesicles for oral vaccines developed

DrugLogic, Inc. - Qscan Version 3 launched

Fukuoka University - Maximum tolerable dose of red pepper decreases fat intake

Genaera Corp. - Company reaches clinical milestone related to IL-9 antibody alliance

Genelabs Technologies, Inc. - Prestara clinical trial GL02-01 for women with lupus is complete

Genentech, Inc. - Rituximab-mediated depletion of healthy B cells elucidated

General Dynamics - Contract awarded for joint biological point detection systems

Genetronics Biomedical Corp. - Electroporation-focused company report Q2 net loss of $2.2 million

George Pompidou European Hospital - Peginterferon may cause sustained cryoglobulinemia-related vasculitis

GlycoGenesys, Inc. - Drug-development company discusses second-quarter losses

Hantavirus - CDC looking for cause of hantavirus as victim recovers

Harbor-UCLA Medical Center - Researchers identify mechanism underlying inflammatory joint disease

Harvard University - Cardiac effects of carbon monoxide, ambient particles studied in a rat MI model

Hemagen Diagnostics, Inc. - FDA issues 510(k) clearance for liquid stable reagents

Inion - Trinion Meniscus Screw receives FDA 510(k) clearance

Kyorin University, Tokyo - Probiotic treatment prevents/treats enterohemorrhagic E. coli O157:H7 infection

Medical Errors - Madisonville, Kentucky, hospital reviewing thousands of medical scans

Miravant Medical Technologies - Clinical results for SnET2 presented at ASRS meeting

POINT Biomedical Corporation - Ultrasound-imaging company raises $27.1 million in equity financing

Purdue University - Bright idea could improve blood safety, spell trouble for cancer and viruses

Rubicon Medical Corporation - Vascular medical device developer and Boston Scientific collaborate

U.S. Army - Lab's experience managing potential threats offers guidelines for others

U.S. Food & Drug Administration - FDA's regulatory role in the ICCVAM process outlined

U.S. Food & Drug Administration - Modifications of Charm II assay for chloramphenicol in honey described

Univ. of California, Irvine - Scientists to develop vaccine to combat bioterrorism threat from deadly bacteria

University of Texas SW Medical Center - IRF-3 target genes constrain WNV infection and limit cell-to-cell virus spread

West Nile Virus - 83-year-old man is first Westchester, New York, resident with West Nile

West Nile Virus - Sixteen new West Nile cases, one death, reported in Louisiana

West Nile Virus - West Nile virus found in Oregon horses

Yale University - Novel method estimates time and size of bioterror attack for real-time use

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook